Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Grabner

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Research Square|January 10, 2024
Fibroblast Growth Factor (FGF) 23 and FGF Receptor 4 promote cardiac metabolic remodeling in chronic kidney diseaseMichaela A Fuchs, Emily J Burke, Nejla Latic, et al.
Scientific Reports|May 5, 2022
FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetesChristopher Yanucil, Dominik Kentrup, Xueyi Li, et al.
The European Respiratory Journal|May 12, 2018
Fibroblast growth factor 23 and Klotho contribute to airway inflammationStefanie Krick, Alexander Grabner, Nathalie Baumlin, et al.
Kidney International|May 5, 2022
Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney diseaseChristopher Yanucil, Dominik Kentrup, Isaac Campos, et al.
Kidney International|February 9, 2025
Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney diseaseMichaela A A Fuchs, Emily J Burke, Nejla Latic, et al.
Cell Metabolism|October 7, 2015
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular HypertrophyAlexander Grabner, Ansel P Amaral, Karla Schramm, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Research Square|January 10, 2024
Fibroblast Growth Factor (FGF) 23 and FGF Receptor 4 promote cardiac metabolic remodeling in chronic kidney diseaseMichaela A Fuchs, Emily J Burke, Nejla Latic, et al.
Scientific Reports|May 5, 2022
FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetesChristopher Yanucil, Dominik Kentrup, Xueyi Li, et al.
The European Respiratory Journal|May 12, 2018
Fibroblast growth factor 23 and Klotho contribute to airway inflammationStefanie Krick, Alexander Grabner, Nathalie Baumlin, et al.
Kidney International|May 5, 2022
Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney diseaseChristopher Yanucil, Dominik Kentrup, Isaac Campos, et al.
Kidney International|February 9, 2025
Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney diseaseMichaela A A Fuchs, Emily J Burke, Nejla Latic, et al.
Cell Metabolism|October 7, 2015
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular HypertrophyAlexander Grabner, Ansel P Amaral, Karla Schramm, et al.
Pageof 4